This Week's Biotech IPOs

(RTTNews) - Although there was no IPO activity in the healthcare sector in the first half of July, there was a steady stream of new offerings in the second half - with 10 companies making their public debut.

Let's take a look at what's in store on the biotech IPO front this week.

Bionano Genomics Inc.

Bionano Genomics is a life sciences instrumentation company in the genome analysis space. The Company markets Saphyr system, which features a suite of tools for fast and comprehensive analysis of human and other species complex genome structure.

The Company is scheduled to list its IPO on the Nasdaq Global Market, under the symbol "BNGO" this week.

Bionano Genomics has offered to sell 3.35 million shares of its common stock in the offering, and the underwriters have an option for a period of 30 days to purchase up to 502,500 additional shares of common stock.

The initial public offering price is expected to be between $8.00 and $10.00 per share.

The Company derives revenue from sales of Saphyr system. The annual revenues in 2017 were $9.5 million, representing approximately 40% growth over the prior year. For the first half of 2018, the revenues were $5.2 million compared to $3.9 million in the prior year comparable period.

Bionano Genomics has incurred losses since inception, and as of June 30, 2018, had an accumulated deficit of $61.4 million.